SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRER14A - Preliminary Proxy Soliciting materials:
SEC Accession No. 0001558370-23-006233
Filing Date
2023-04-19
Accepted
2023-04-19 17:19:43
Documents
20

Document Format Files

Seq Description Document Type Size
1 PRER14A iova-20221231xprer14a.htm   iXBRL PRER14A 1976569
2 GRAPHIC iova-20221231xprer14a002.jpg GRAPHIC 15019
3 GRAPHIC iova-20221231xprer14a009.jpg GRAPHIC 38039
4 GRAPHIC iova-20221231xprer14a020.jpg GRAPHIC 44030
5 GRAPHIC iova-20221231xprer14a021.jpg GRAPHIC 36226
6 GRAPHIC iova-20221231xprer14a023.jpg GRAPHIC 189139
7 GRAPHIC iova-20221231xprer14a024.jpg GRAPHIC 129854
  Complete submission text file 0001558370-23-006233.txt   4645911

Data Files

Seq Description Document Type Size
8 EX-101.SCH iova-20221231.xsd EX-101.SCH 5760
9 EX-101.DEF iova-20221231_def.xml EX-101.DEF 7874
10 EX-101.LAB iova-20221231_lab.xml EX-101.LAB 13813
11 EX-101.PRE iova-20221231_pre.xml EX-101.PRE 7256
14 EXTRACTED XBRL INSTANCE DOCUMENT iova-20221231xprer14a_htm.xml XML 554965
Mailing Address 825 INDUSTRIAL ROAD 4TH FLOOR SAN CARLOS CA 94070
Business Address 825 INDUSTRIAL ROAD 4TH FLOOR SAN CARLOS CA 94070 6502607120
IOVANCE BIOTHERAPEUTICS, INC. (Filer) CIK: 0001425205 (see all company filings)

IRS No.: 753254381 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRER14A | Act: 34 | File No.: 001-36860 | Film No.: 23830795
SIC: 2836 Biological Products, (No Diagnostic Substances)